Article

Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study…

medRxiv · 2022 · Bailey Lubinski, author Laura E. Frazier, author My V.T. Phan, author Daniel L. Bugembe, author Jessie L. Cunningham, author Tiffany Tang, author Susan Daniel, author Matthew Cotten, author Javier A. Jaimes, author Gary R. Whittaker, author

Key facts

Title Spike protein cleavage-activation mediated by the SARS-CoV-2 P681R mutation: a case-study from its first appearance in variant of interest (VOI) A.23.1 identified in Uganda
First author Bailey Lubinski, author Laura E. Frazier, author My V.T. Phan, author Daniel L. Bugembe, author Jessie L. Cunningham, author Tiffany Tang, author Susan Daniel, author Matthew Cotten, author Javier A. Jaimes, author Gary R. Whittaker, author
Journal medRxiv
Published Mar 28, 2022
DOI 10.1101/2021.06.30.450632
Devices mentioned BK110039, DEN000008, K022086, K073490, K103302, K863802
Product codes mentioned CFN, JCI, KIT, NDS, NJT, OOI, JJQ, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature